<bill session="109" type="s" number="529" updated="2014-12-10T13:46:05-05:00">
  <state datetime="2006-09-27">REPORTED</state>
  <status>
    <unknown datetime="2006-09-27"/>
  </status>
  <introduced datetime="2005-03-03"/>
  <titles>
    <title type="official" as="introduced">A bill to designate a United States Anti-Doping Agency.</title>
  </titles>
  <sponsor id="300048"/>
  <cosponsors>
    <cosponsor id="300008" joined="2005-03-03"/>
    <cosponsor id="300071" joined="2005-03-03"/>
    <cosponsor id="300094" joined="2005-03-03"/>
  </cosponsors>
  <actions>
    <action datetime="2005-03-03">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S2044"/>
    </action>
    <action datetime="2005-03-03" state="REFERRED">
      <text>Read twice and referred to the Committee on Commerce, Science, and Transportation.</text>
      <reference ref="CR S2044" label="text of measure as introduced"/>
    </action>
    <action datetime="2005-05-24">
      <text>Committee on Commerce, Science, and Transportation. Hearings held. Hearings printed: S.Hrg. 109-212.</text>
    </action>
    <calendar datetime="2006-09-27" state="REPORTED">
      <text>Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment favorably.</text>
    </calendar>
  </actions>
  <committees>
    <committee code="SSCM" name="Senate Commerce, Science, and Transportation" activity="Referral, Hearings, Markup, In Committee"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Sports and recreation"/>
    <term name="Associations, institutions, etc."/>
    <term name="Auditing"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Drug abuse"/>
    <term name="Drug abuse prevention"/>
    <term name="Drug testing"/>
    <term name="Drugs and athletes"/>
    <term name="Finance and financial sector"/>
    <term name="Olympic games"/>
    <term name="Steroids"/>
  </subjects>
  <amendments/>
  <summary>3/3/2005--Introduced.
Designates the United States Anti-Doping Agency to: (1) serve as the independent anti-doping organization for the amateur athletic competitions recognized by the U.S. Olympic Committee; (2) ensure that athletes participating in such competitions are prevented from using performance-enhancing drugs; (3) implement anti-doping education, research, testing, and adjudication programs to prevent U.S. amateur athletes from using performance-enhancing drugs; and (4) serve as the U.S. representative for coordination with other anti-doping organizations coordinating amateur athletic competitions.</summary>
</bill>
